Hong Kong Respiratory Medicine

Luke Howard, Nina Salooja. The Lancet, Early Online Publication, 23 June 2011. doi:10.1016/S0140-6736 (11) 60932-X
In The Lancet , Drahomir Aujesky and colleague present a non-inferiority trial of outpatient versus inpatient treatment of low-risk acute pulmonary embolism.
 
The primary endpoint was symptomatic, recurrent venous thromboembolism within 90 days; secondary outcomes included major bleeding within 14 or 90 days, and mortality and medical resource use within 90 days. All patients received subcutaneous enoxaparin (1 mg/kg twice every day) for at least 5 days, followed by anticoagulation treatment for 9 ...

Read More